Litcius/Paper detail

High‐fat diet‐induced adipose tissue expansion occurs prior to insulin resistance in C57BL/6J mice

Mingqian He, Jingya Wang, Yue Wang, Jing Sui, Meng Zhang, Xi Ding, Zhao Yang, Ziyi Chen, Xiao‐Xiao Ren, Bingyin Shi

2020Chronic Diseases and Translational Medicine52 citationsDOIOpen Access PDF

Abstract

Abstract Background To date, there is only scare evidence characterizing the temporal features and progression of metabolic dysfunction in high‐fat diet (HFD)‐fed obese mice. Hence, its specific pathogenesis remains unclear. Methods Sixty 6‐week‐old male C57BL/6J mice were randomly divided into HFD and control diet (CD) groups and sacrificed at 1, 5, 9, 13, 17, and 21 weeks, respectively. At weekly intervals, intraperitoneal glucose tolerance testing (IPGTT) and intraperitoneal insulin tolerance testing (IPITT) were performed in both groups. A detailed time course in HFD‐fed mice was investigated by evaluating the initiation of glucose homeostasis impairment, dyslipidemia, systemic insulin sensitivity, monocyte chemoattractant protein‐1 (MCP‐1) levels, epididymal white adipose tissue (eWAT) expansion, macrophage content changes, pro‐inflammatory (M1)/anti‐inflammatory (M2) macrophage imbalance, lipid accumulation in the liver, and β‐cell morphometry in the pancreas. Results In the HFD group, progressive weight gain and impairments in glucose metabolism (elevated fasting blood glucose and area under the curve (AUC) of IPGTT) were observed from the 3rd week, and a significantly elevated AUC of IPITT was first detected after week 7 of HFD feeding. As for dyslipidemia, after 9 weeks of feeding, the low‐density lipoprotein cholesterol level and total cholesterol level in HFD group were significantly higher than those in the CD group (all P < 0.05), whereas no significant differences were shown in triglyceride level. Adipocyte size increased significantly in the HFD group in the 1st week, a phenotypic switch in eWAT from anti‐inflammatory (M2) to pro‐inflammatory (M1) macrophages was observed in the 5th week, and the metabolic inflammation was distinct in eWAT in the 9th week. Additionally, liver steatosis was considerably obvious at the 17th week and pancreatic β‐cell morphometry did not change during 21 weeks of HFD feeding. Conclusion The eWAT expansion was detected early in HFD‐induced obese mice, which occurred prior to obvious insulin resistance.

Topics & Concepts

Internal medicineEndocrinologyInsulin resistanceDyslipidemiaMedicineAdipose tissueTriglycerideGlucose homeostasisWhite adipose tissueAdipocyteGlucose tolerance testInsulin tolerance testInsulinImpaired glucose toleranceCholesterolObesityInsulin sensitivityAdipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismRegulation of Appetite and Obesity